openPR Logo
Press release

Chronic Myeloid Leukemia Treatment Market - Global Industry Insights, Trends, 2026

07-06-2018 12:31 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Chronic Myeloid Leukemia Treatment Market - Global Industry

Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a blood-cell cancer that begins in the blood-forming cells of the bone marrow. Myeloid cells are a type of immature cells that are capable of making white blood cells and when these cells continue to grow in an abnormal condition, it turns into a chronic myeloid leukemia condition. This cancer majorly causes fatigue, fever, easy bleeding, infection, bone pain, anemia, and swollen spleen among the patients who are middle-aged people or older, though it can occur in children also. CML is a slowly growing leukemia, however, it can also change into a fast-growing acute leukemia, which is harder to treat. Continuous support from the government by approving the pipeline drugs for CML is expected to propel growth of the market over the forecast period. For instance, in February 2014, Teva Pharmaceutical Industries Ltd.’s drug, SYNRIBO (omacetaxine mepesuccinate) for adult patients with chronic phase or accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors (TKIs) got the U.S. FDA approval.

To get holistic SAMPLE of the report including table of contents: https://www.coherentmarketinsights.com/insight/request-sample/1726

Chronic Myeloid Leukemia Treatment Market Drivers

Increasing number of researches that are being carried out to identify the causes of CML cancer is expected to boost growth of the chronic myeloid leukemia treatment market over the forecast period. Targeted drug known as tyrosine-kinase inhibitors (TKIs) have been effective in providing long-term survival rates. Furthermore, the Food and Drug Administration (FDA) approved dasatinib (Sprycel) for the treatment of chronic myeloid leukemia in pediatrics in 2017. Researchers are also focusing on polypharmacology approach to develop drugs that can act on multiple targets. This is leading to the drug discovery opportunities that are beyond the concept of ‘one drug, one target’.

As chronic myeloid leukemia is more aggressive in younger patients, the approval of drugs can help in effective treatment. Moreover, with the development of imatinib and the second generation TKIs, dasatinib and nilotinib, small molecule drugs have become the mainstay for the first-line CML management. However, high cost of the drugs used for this disease is a major restraint affecting the growth of the market. For instance, TKIs drugs are very expensive and therefore, generic drugs are being introduced in various countries. Increasing prevalence of this cancer in various regions is expected to drive growth of the market over the forecast period. For instance, according to an article published in UBM Medica LLC, CML accounts for around 15% of the total leukemia cases in adults. Approximately 8,220 new cases of CML were diagnosed in 2016, with an estimated 1,070 deaths. The age-adjusted incidence is 1.6 per 100,000 population.

Chronic Myeloid Leukemia Treatment Market - Regional Analysis

On the basis of region, the global chronic myeloid leukemia market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to gain significant traction in the chronic myeloid leukemia treatment market, followed by Europe, owing to increasing prevalence of chronic myelogenous leukemia in developed economies due to genetic factors. According to the America Cancer Society, around 8,430 new cases of CML will be observed (4,980 in men and 3,450 in women) in 2018 and around 1,090 people will die due to CML (620 men and 470 women). However, improving healthcare infrastructure in emerging economies such as China and India are contributing towards the growth of chronic myeloid leukemia treatment market in the Asia Pacific region.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/chronic-myeloid-leukemia-treatment-market-1726

Chronic Myeloid Leukemia Treatment Market – Competitive Landscape

Tough competition between major players to retain their market share in CML market may provide opportunities to come up with altered solutions in drug development and new strategies to embrace the mindset of the end users. Since 2015, majority of the drugs offered by major players for this condition were approved. There are commercialized products, which include Bristol Meyer Squibb’s Sprycel (approved in December, 2017), Novartis’s Gleevec and Tasigna (approved in March, 2018), Takeda Pharmaceuticals’ Iclusig (approved in 2018), and Pfizer’s Bosulif (approved in December, 2017).

The market players operating in the chronic myeloid leukemia treatment market include Teva Pharmaceuticals Industries Ltd., Hoffman-La Roche Ltd., Novartis AG, Bristol-Myers Squibb, Pfizer, Inc Hospira, Inc., Prism Pharmaceuticals, Incyte Corporation, Bio-Path Holdings, Stragen Pharma SA, and Otsuka Pharmaceutical Co., Ltd among others.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Blog: https://globalresearchtrends.blogspot.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Myeloid Leukemia Treatment Market - Global Industry Insights, Trends, 2026 here

News-ID: 1113612 • Views: 283

More Releases from Coherent Market Insights

Sterile Injectables Market to expand business growth Key Manufacturers Analysis …
The Latest research study released by CMI "Global Sterile Injectables Market" with 360+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth. This report likewise contemplates the worldwide Sterile Injectables market status, rivalry
Weight Loss and Obesity Management Market SWOT Analysis, Key Companies, CAGR Sta …
Obesity is characterized as the accumulation of excess body fat. Diseases and the promotion of an unhealthy lifestyle are two main contributors to obesity around the world. Drugs, dietary supplements, bariatric surgery (weight reduction surgery), and exercise are some of the techniques used to treat weight loss and obesity. As per the World Health Organization (WHO), a person is overweight if their BMI is greater than or equal to 25,
Naloxone Market Future Outlook with Key Focus on Global 2021-2028 | Mylan N.V., …
The latest report put out by Coherent Market Insights on the global Naloxone Market offers an in-depth analysis of prominent players, key market drivers, global revenue, market segments, and their sub-segments. The market study also involves major geographic regions and revenue forecasts for the regions as well as their countries. The report assesses the market size in terms of value for the forecast period of 2020-2027. Get Sample Report with Latest
eHealth Software and Services Market Latest Development with Key Manufacturers A …
The recent outbreak of pandemic is a prime factor fostering the growth of the eHealth software and services market. For instance, in August 2020, there have been 18,318,928 confirmed cases of COVID-19, including 695,043 deaths, globally, as reported to World Health Organization. The increasing launch of innovative eHealth software and services is again expected to aid in the growth of the market. For instance, in June 2020, Fitbit launched a

All 5 Releases


More Releases for CML

Light blue tube phlebotomy Market Foreseen to Grow With Key Companies Like Grein …
Various tests are performed using the light blue phlebotomy tube. Some of them are Partial Thromboplastin Time (PTT), Fibrin degradation products (FDP), Thrombin Time (TT), Prothrombin Time (PT), Fibrinogen, and D-dimer. The global light blue tube phlebotomy market is expected to swell at a considerable rate in the near future. Rise in health awareness has resulted in the increase in blood diagnostic tests; particularly coagulation tests owing to mounting incidences
Specialty Lighting Market Research Report 2018 Top Companies Analysis: Philips L …
Specialty Lighting Market documents a detailed study of different aspects of the Global Specialty Lighting Market. It shows the steady growth in market in spite of the fluctuations and changing market trends. In the past four years the Global Specialty Lighting Market has grown to a booming value of $xxx million and is expected to grow more. Get Sample Copy of This Report at https://www.orbisresearch.com/contacts/request-sample/2443970 Every market intelligence report is based on
Digital Signal Processor Market Growth Analysis By Top Key Players - Wolfson Mic …
MarketStudyReport.com Adds New Digital Signal Processor Market 2018 – 2023 research report providing information and data By Technology, By Application, By Segmentation, By End-Use, By Product, Industry Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast spreading across 110 Pages with table and figures in it. Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the
Specialty Lighting Market Size 2017-2022: Waldmann, Philips Lighting, CML Techno …
Specialty Lighting Market Research 2017 A market study ” Global Specialty Lighting Market ” examines the performance of the Specialty Lighting market 2017. It encloses an in-depth Research of the Specialty Lighting market state and the competitive landscape globally. This report analyzes the potential of Specialty Lighting market in the present and the future prospects from various angles in detail. The Global Specialty Lighting Market 2017 report includes Specialty Lighting market Revenue,
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Tria …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2017 provides an overview of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia). Report includes an overview of
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, T …
Orbisreserach.Com Adds “H1 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2017, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape. Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the